Consider these medications to help patients stay sober

dc.contributor.author	Hendry, Sydney	eng
dc.contributor.author	Mounsey, Anne L.	eng
dc.contributor.other	Family Physicians Inquiries Network	eng
dc.date.issued	2015	eng
dc.description.abstract	Naltrexone can help prevent relapse in recently detoxified patients with alcohol use disorder. The evidence for acamprosate is not quite as strong. Practice changer: Consider prescribing oral naltrexone (50 mg/d) for patients with alcohol use disorder who wish to maintain abstinence after a brief period of detoxification.	eng
dc.identifier.uri	https://hdl.handle.net/10355/45953
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Priority Updates to Research Literature (PURLs) (2015)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 64, no. 04 (April 2015): 238-240.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject.other	Sober	eng
dc.subject.other	Alcohol abuse	eng
dc.subject.other	Naltrexone	eng
dc.subject.other	Relapse prevention	eng
dc.subject.other	Acamprosate	eng
dc.title	Consider these medications to help patients stay sober	eng
dc.type	Article	eng

Priority Updates to Research Literature (PURLs)
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.